South Dakota’s hydroxychloroquine trial discontinued
The statewide hydroxychloroquine trial, a collaboration among Sanford Health, Avera Health and Monument Health, and sponsored by the state of South Dakota, has been discontinued.
The statewide hydroxychloroquine trial, a collaboration among Sanford Health, Avera Health and Monument Health, and sponsored by the state of South Dakota, has been discontinued.
COVID-19 patients whose physicians agree they could benefit from the antimalarial drug hydroxychloroquine will be able to access the drug at all major health systems in South Dakota, and those who have been exposed might be eligible to take the drug as part of a controlled study led by Sanford Health.